State of the Art and Consensus Statements by Healthcare Providers, Patients, and Caregivers on Continuous Glucose Monitoring in Liver Glycogen Storage Diseases
Journal of Inherited Metabolic Disease · 2025-05 · 48 (3)
DOI: 10.1002/jimd.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 13.05.2025. Verfasst von Terry G J Derks und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlan…. Hauptthemen laut MEDLINE: Blood Glucose, Blood Glucose Self-Monitoring, Glycogen Storage Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Continuous glucose monitoring (CGM) is increasingly used although not officially registered for the management of people living with liver glycogen storage diseases (GSDs). The aims of this study were twofold: (a) to investigate the current experiences of healthcare providers (HCPs), patients, and caregivers using CGM to monitor glucose concentrations in liver GSDs, and (b) to formulate consensus statements. Two web‐based questionnaires were distributed, one for HCPs and one for patients and/or their caregivers. The questionnaires collected data on demographics and epidemiology, current use of CGM, and opinions and statements about CGM in GSDs. For the statements, respondents rated their agreement on a 5‐point Likert scale, and the consensus level was set at 75%. One Hundred Fourteen HCPs (including 87 physicians and 26 dietitians) from 28 countries responded, representing care of approximately 3800 liver GSD patients. Additionally, 148 GSD patients and/or their caregivers from 21 countries responded, mainly representing GSD Ia ( n = 50), GSD Ib ( n = 56), GSD III ( n = 14), and GSD IX ( n = 18). The median age to consider starting to use CGM was 6 and 2 months for HCPs and GSD families, respectively. Out of 16 statements common to the two questionnaires, HCPs and patients/caregivers reached consensus on 12 statements in both groups. Use of CGM is considered standard of care by both HCPs and GSD families, but reimbursement of CGM devices is challenging. Compared to diabetes mellitus, CGM should be applied differently in liver GSDs. Consensus guidelines are warranted on the use of CGM in liver GSDs, both in routine healthcare and in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- UMCG Center of Expertise for Carbohydrate, Fatty Acid Oxidation and Ketone Bodies Disorders, University Medical Center Groningen, Groningen, the Netherlands.
- Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
- Department of Translational Medicine, Section of Pediatrics, University of Naples "Federico II", Naples, Italy.
ORCID-Profile: Terry G J Derks, Ruben J Overduin, Sarah C Grünert, Alessandro Rossi
Zitieren
APA
Derks, T. G. J., Overduin, R. J., Grünert, S. C., Rossi, A., & CGM GSD Collaborators Group (2025). State of the Art and Consensus Statements by Healthcare Providers, Patients, and Caregivers on Continuous Glucose Monitoring in Liver Glycogen Storage Diseases. Journal of Inherited Metabolic Disease, 48(3). https://doi.org/10.1002/jimd.70040
Vancouver
Derks TGJ, Overduin RJ, Grünert SC, Rossi A, CGM GSD Collaborators Group. State of the Art and Consensus Statements by Healthcare Providers, Patients, and Caregivers on Continuous Glucose Monitoring in Liver Glycogen Storage Diseases. Journal of Inherited Metabolic Disease. 2025;48(3). doi:10.1002/jimd.70040
BibTeX
@article{Derks2025,
author = {Derks, Terry G J and Overduin, Ruben J and Grünert, Sarah C and Rossi, Alessandro and CGM GSD Collaborators Group, CGM GSD Collaborators Group},
title = {State of the Art and Consensus Statements by Healthcare Providers, Patients, and Caregivers on Continuous Glucose Monitoring in Liver Glycogen Storage Diseases},
journal = {Journal of Inherited Metabolic Disease},
year = {2025},
volume = {48},
number = {3},
doi = {10.1002/jimd.70040}
}
EUVIMED